BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 31326373)

  • 1. The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new.
    Chanson P; Maiter D
    Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101290. PubMed ID: 31326373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactinomas.
    Wildemberg LE; Fialho C; Gadelha MR
    Presse Med; 2021 Dec; 50(4):104080. PubMed ID: 34687915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactinomas.
    Glezer A; Bronstein MD
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
    Vilar L; Abucham J; Albuquerque JL; Araujo LA; Azevedo MF; Boguszewski CL; Casulari LA; Cunha Neto MBC; Czepielewski MA; Duarte FHG; Faria MDS; Gadelha MR; Garmes HM; Glezer A; Gurgel MH; Jallad RS; Martins M; Miranda PAC; Montenegro RM; Musolino NRC; Naves LA; Ribeiro-Oliveira Júnior A; Silva CMS; Viecceli C; Bronstein MD
    Arch Endocrinol Metab; 2018; 62(2):236-263. PubMed ID: 29768629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on prolactinomas. Part 2: Treatment and management strategies.
    Wong A; Eloy JA; Couldwell WT; Liu JK
    J Clin Neurosci; 2015 Oct; 22(10):1568-74. PubMed ID: 26243714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinemia and prolactinomas.
    Mancini T; Casanueva FF; Giustina A
    Endocrinol Metab Clin North Am; 2008 Mar; 37(1):67-99, viii. PubMed ID: 18226731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolactinoma].
    Krysiak R; Okopień B; Marek B; Szkróbka W
    Przegl Lek; 2009; 66(4):198-205. PubMed ID: 19708510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prolactinoma].
    Glezer A; Bronstein MD
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):118-23. PubMed ID: 24830588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on prolactinomas. Part 1: Clinical manifestations and diagnostic challenges.
    Wong A; Eloy JA; Couldwell WT; Liu JK
    J Clin Neurosci; 2015 Oct; 22(10):1562-7. PubMed ID: 26256063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GIANT PROLACTINOMA. A CASE REPORT.
    Šulavíková Z; Krásnik V
    Cesk Slov Oftalmol; 2023; 79(3):143-148. PubMed ID: 37344216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperprolactinemia unrelated to prolactinoma].
    Krysiak R; Okopień B
    Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia after menopause: Diagnosis and management.
    Auriemma RS; Pirchio R; Pivonello R; Colao A
    Maturitas; 2021 Sep; 151():36-40. PubMed ID: 34446277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some issues in the diagnosis and treatment of hyperprolactinemia].
    Jin ZM
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):241-3. PubMed ID: 18843959
    [No Abstract]   [Full Text] [Related]  

  • 15. T2-weighted magnetic resonance imaging characterization of prolactinomas and association with their response to dopamine agonists.
    Burlacu MC; Maiter D; Duprez T; Delgrange E
    Endocrine; 2019 Feb; 63(2):323-331. PubMed ID: 30267354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current diagnosis and treatment of hyperprolactinemia].
    Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.
    Casanueva FF; Molitch ME; Schlechte JA; Abs R; Bonert V; Bronstein MD; Brue T; Cappabianca P; Colao A; Fahlbusch R; Fideleff H; Hadani M; Kelly P; Kleinberg D; Laws E; Marek J; Scanlon M; Sobrinho LG; Wass JA; Giustina A
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):265-73. PubMed ID: 16886971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to the Patient With Prolactinoma.
    Auriemma RS; Pirchio R; Pivonello C; Garifalos F; Colao A; Pivonello R
    J Clin Endocrinol Metab; 2023 Aug; 108(9):2400-2423. PubMed ID: 36974474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia: pathophysiology and management.
    Verhelst J; Abs R
    Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperprolactinemia and prolactinomas].
    Croughs RJ; van 't Verlaat JW
    Ned Tijdschr Geneeskd; 1991 Nov; 135(47):2210-3. PubMed ID: 1956454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.